Cleared Traditional

K211725 - Senographe Pristina

K211725 is the FDA 510(k) clearance for Senographe Pristina by Ge Healthcare. It is a Class 2 Radiology device (product code MUE) cleared through the Traditional 510(k) pathway after a 63-day FDA review.

K211725 · Ge Healthcare · Radiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Aug 2021
Decision
63d
Days
Class 2
Risk

K211725 is an FDA 510(k) clearance for the Senographe Pristina. Classified as Full Field Digital, System, X-ray, Mammographic (product code MUE), Class II - Special Controls.

Submitted by Ge Healthcare (Buc, FR). The FDA issued a Cleared decision on August 6, 2021 after a review of 63 days - a notably fast clearance cycle.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.1715 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Ge Healthcare devices

Submission Details

510(k) Number K211725 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received June 04, 2021
Decision Date August 06, 2021
Days to Decision 63 days
Submission Type Traditional
Review Panel Radiology (RA)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
44d faster than avg
Panel avg: 107d · This submission: 63d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code MUE Full Field Digital, System, X-ray, Mammographic
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.1715
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Radiology devices follow this clearance model.

Regulatory Peers - MUE Full Field Digital, System, X-ray, Mammographic

All 38
Devices cleared under the same product code (MUE) and FDA review panel - the closest regulatory comparables to K211725.
Aspire Cristalle
K212873 · Fujifilm Corporation · May 2022
Digimamo D
K210151 · Vmi Tecnologias Ltda · Mar 2022
Helianthus
K202822 · Metaltronica Spa · Dec 2021
SenoBright HD
K211215 · Ge Healthcare · Jun 2021
2430MCA with Xmaru W
K202902 · Rayence Co., Ltd. · Jun 2021
Planmed Clarity 2D and Clarity S
K192317 · Planmed OY · Oct 2020